Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1683750
Max Phase: Preclinical
Molecular Formula: C20H27N9O11S3
Molecular Weight: 665.69
Molecule Type: Small molecule
Associated Items:
ID: ALA1683750
Max Phase: Preclinical
Molecular Formula: C20H27N9O11S3
Molecular Weight: 665.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)c1csc([C@@H]2O[C@H](CNS(=O)(=O)CS(=O)(=O)NC[C@@H]3O[C@H](n4cnc5c(N)ncnc54)[C@@H](O)[C@H]3O)[C@@H](O)[C@H]2O)n1
Standard InChI: InChI=1S/C20H27N9O11S3/c21-16-10-18(24-4-23-16)29(5-25-10)20-14(33)12(31)9(40-20)2-27-43(37,38)6-42(35,36)26-1-8-11(30)13(32)15(39-8)19-28-7(3-41-19)17(22)34/h3-5,8-9,11-15,20,26-27,30-33H,1-2,6H2,(H2,22,34)(H2,21,23,24)/t8-,9+,11-,12+,13-,14+,15-,20+/m1/s1
Standard InChI Key: QXTCYJUSNXVKHY-VSKCBFOOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 665.69 | Molecular Weight (Monoisotopic): 665.0992 | AlogP: -4.76 | #Rotatable Bonds: 11 |
Polar Surface Area: 317.32 | Molecular Species: NEUTRAL | HBA: 18 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.14 | CX Basic pKa: 4.92 | CX LogP: -5.32 | CX LogD: -5.38 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.10 | Np Likeness Score: 0.15 |
1. Felczak K, Chen L, Wilson D, Williams J, Vince R, Petrelli R, Jayaram HN, Kusumanchi P, Kumar M, Pankiewicz KW.. (2011) Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain., 19 (5): [PMID:21324702] [10.1016/j.bmc.2011.01.042] |
Source(1):